INTERNATIONAL PATENT: ALIGOS THERAPEUTICS, INC. FILES APPLICATION FOR "MODULATORS OF THR-BETA AND METHODS OF USE THEREOF"

GENEVA, July 3 -- ALIGOS THERAPEUTICS, INC. (1 Corporate Drive, 2nd FloorSouth San Francisco, CA 94080) filed a patent application (PCT/US2024/061454) for "MODULATORS OF THR-BETA AND METHODS OF USE THEREOF" on Dec 20, 2024. With publication no. WO/2025/137568, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MCGOWAN, David, Craig (Av de biolley 801150 Brussels), GUPTA, Kusum, S. (3508 Bering DriveSan Bruno, CA 94066)

Abstract: Disclosed herein are compounds of Formula I: or a stereoisomer or a tautomer thereof; or a pha...